Study guide
8.4 Acyanotic Congenital Heart Lesions, Patent Ductus Arteriosus, Obstructed TAPVR & Neonatal Heart Failure
Neonatal Pediatric Transport C-NPT
Track your progress as you read
Finished sections get a check mark.
1 Introduction: The C-NPT Exam
About the C-NPT Exam: 2026 Format, Eligibility & Content Outline
2 Chapter 1: Transport Systems, Regulatory Framework & Legal Issues
1.1 Transport System Architecture, Accreditation (CAMTS) & Dispatch Triage 1.2 Regulatory & Legal Mandates: EMTALA, HIPAA, Consent & Documentation 1.3 Medical Direction, Scope of Practice & Ethical Considerations
3 Chapter 2: Safety, Communication, Crew Resource Management & Transport Environment
2.1 Crew Resource Management (CRM), Situational Awareness & Sterile Cockpit 2.2 Aircraft & Ground Ambulance Operations, Landing Zones & Vehicle Dynamics 2.3 Environmental Hazards, Weather Minimums & In-Flight Emergency Procedures 2.4 Communication in Transport: Peer Handoffs, Age-Appropriate Care, Families & Crew Stressors 2.5 Infection Control, PPE, Scene Safety & Disaster/Evacuation Planning
4 Chapter 3: Flight Physiology & Environmental Stressors
3.1 Physical Gas Laws & Transport Implications (Boyle, Dalton, Charles, Henry, Graham) 3.2 Altitude Hypoxia, Barometric Pressure Changes & Dysbarism 3.3 Acceleration Forces (G-forces), Vibration & Acoustic Stress in Transit 3.4 Thermoregulation Physics & Neutral Thermal Environment in Transit
5 Chapter 4: Invasive Procedures & Transport Monitoring
4.1 Advanced Airway Management & Endotracheal Intubation in Transit 4.2 Pleural Decompression (Needle Thoracostomy & Chest Tube Management) 4.3 Vascular Access: Umbilical Lines (UAC/UVC), Intraosseous (IO) & Arterial Lines
6 Chapter 5: Transport Equipment, Respiratory Physiology & Mechanical Ventilation
5.1 Transport Incubators (Isolettes), Thermal Control & Electrical/Gas Power Systems 5.2 Portable Ventilators & Modes (PC, VC, PRVC, High Frequency) 5.3 Gas Cylinder Duration Calculations, Oxygen Delivery & Inhaled Nitric Oxide (iNO) 5.4 Respiratory Physiology: Acid-Base Balance, Oxygenation, Lung Mechanics & Troubleshooting
7 Chapter 6: Transport Pharmacology, Resuscitation, Fluids & Electrolytes
6.1 Vasoactive Infusions & Inotropes (Epinephrine, Dopamine, Dobutamine, Milrinone) 6.2 Sedation, Analgesia & Neuromuscular Blockade in Transport 6.3 Prostaglandin E1 (Alprostadil) & Surfactant Replacement Therapy 6.4 Resuscitation Protocols (NRP, PALS) & Shock Fluid Resuscitation 6.5 Antimicrobial Pharmacology in Neonatal & Pediatric Transport 6.6 Post-Resuscitation Care, Defibrillation & Cardioversion in Transit, ECMO Indications & the Transport-vs-Stay Decision 6.7 Fluid & Electrolyte Therapy Across the Ages: Maintenance, Dehydration, Fluid Overload & Electrolyte Emergencies
8 Chapter 7: Neonatal Respiratory Pathologies & Management
7.1 Respiratory Distress Syndrome (RDS) & Surfactant Deficiency 7.2 Meconium Aspiration Syndrome (MAS) & Persistent Pulmonary Hypertension (PPHN) 7.3 Transient Tachypnea (TTN), Neonatal Pneumothorax & Congenital Diaphragmatic Hernia (CDH) 7.4 Neonatal Upper Airway Anomalies, Aspiration, Pneumonia, Chronic Lung Disease & Respiratory Failure
9 Chapter 8: Neonatal Cardiovascular Critical Care
8.1 Ductal-Dependent Cyanotic Congenital Heart Defects (TGA, TOF, Tricuspid Atresia) 8.2 Ductal-Dependent Systemic Blood Flow Lesions (HLHS, Coarctation, Interrupted Arch) 8.3 Neonatal Arrhythmias, Cardiogenic Shock & Post-Resuscitation Care 8.4 Acyanotic Congenital Heart Lesions, Patent Ductus Arteriosus, Obstructed TAPVR & Neonatal Heart Failure
10 Chapter 9: Neonatal Neurological & Metabolic Crises
9.1 Hypoxic-Ischemic Encephalopathy (HIE) & Passive/Active Therapeutic Hypothermia 9.2 Neonatal Seizures & Intraventricular Hemorrhage (IVH) 9.3 Neonatal Hypoglycemia, Electrolyte Derangements & Hyperbilirubinemia 9.4 Subgaleal Hemorrhage, Neonatal Sepsis & Meningitis, and Perinatal Substance Exposure (NOWS)
11 Chapter 10: Neonatal Surgical Emergencies, Neural Tube Defects & ELBW Care
10.1 Abdominal Wall Defects (Gastroschisis vs. Omphalocele) & TEF/Esophageal Atresia 10.2 Necrotizing Enterocolitis (NEC), Malrotation with Volvulus & Intestinal Obstruction 10.3 Care of the Extremely Low Birth Weight (ELBW) Infant (<1000g) in Transit 10.4 Neural Tube Defects: Myelomeningocele, Encephalocele & Transport of the Newborn With an Open Spinal Defect
12 Chapter 11: Pediatric Respiratory Emergencies
11.1 Acute Upper Airway Obstruction (Croup, Epiglottitis, Bacterial Tracheitis, Foreign Body) 11.2 Lower Airway Crises: Status Asthmaticus & Severe Bronchiolitis 11.3 Pediatric Acute Respiratory Distress Syndrome (PARDS) & Severe Pneumonia
13 Chapter 12: Pediatric Shock & Cardiovascular Crises
12.1 Pathophysiology & Transport Management of Pediatric Septic Shock 12.2 Hypovolemic, Cardiogenic & Anaphylactic Shock in Children 12.3 Pediatric Cardiac Emergencies: SVT, Ventricular Arrhythmias & Myocarditis 12.4 Pediatric Cardiovascular Crises: Palliated Congenital Heart Disease, Pulmonary Hypertensive Crisis, Pericarditis & Tamponade, Hypertensive Emergency & Anterior Mediastinal Mass
14 Chapter 13: Pediatric Neurological Emergencies & Trauma
13.1 Status Epilepticus, Altered Mental Status & Meningitis/Encephalitis 13.2 Pediatric Traumatic Brain Injury (TBI) & Increased Intracranial Pressure (ICP) 13.3 Blunt/Penetrating Trauma, Spinal Motion Restriction & Thermal Burns 13.4 Non-Accidental Trauma, Smoke Inhalation (Carbon Monoxide & Cyanide) & Heat Illness
15 Chapter 14: Pediatric Toxicological, Environmental & Endocrine Emergencies
14.1 Common Pediatric Toxic Ingestions, Poisonings & Antidotes 14.2 Diabetic Ketoacidosis (DKA) & Environmental Emergencies (Submersion, Hypothermia) 14.3 Button Battery & Foreign-Body Ingestions, Bites & Envenomations, and Hazardous-Material Exposures
16 Chapter 15: Pediatric Metabolic & Hematologic Emergencies
15.1 Anemia, Sickle Cell Disease, Coagulopathies & Blood Product Administration 15.2 Oncologic Emergencies, Acute Kidney Injury & Pediatric Electrolyte Crises
8.4 Acyanotic Congenital Heart Lesions, Patent Ductus Arteriosus, Obstructed TAPVR & Neonatal Heart Failure
Key Takeaways Explain This Topic AI
Large left-to-right shunts (VSD, atrioventricular septal defect, large PDA) usually cause heart failure at about 4–8 weeks of age, as pulmonary vascular resistance falls and pulmonary blood flow rises.
A hemodynamically significant PDA in a preterm infant causes bounding pulses, a wide pulse pressure, a continuous or systolic murmur, and pulmonary overcirculation that can steal systemic and mesenteric flow.
In shunt lesions and single-ventricle physiology, high inspired oxygen lowers pulmonary vascular resistance and increases pulmonary overcirculation; oxygen is titrated to the target saturation, not maximized.
Obstructed total anomalous pulmonary venous return presents with severe cyanosis and pulmonary edema, can mimic PPHN, and is a surgical emergency that PGE1 does not fix.
Neonatal heart failure causes tachypnea, poor feeding with sweating, hepatomegaly, and poor growth; transport care uses careful fluids, diuretics, and inotropes rather than large volume boluses.
Last updated: September 2026
Acyanotic Heart Lesions, PDA, Obstructed TAPVR & Neonatal Heart Failure
Sections 8.1 and 8.2 cover ductal-dependent lesions, where closing the ductus is fatal. This section covers lesions that cause trouble through too much pulmonary blood flow (left-to-right shunts), along with one cyanotic emergency that is often misdiagnosed as lung disease.
Left-to-Right Shunt Physiology
At birth, pulmonary vascular resistance (PVR) is still relatively high. Over the first weeks , PVR falls toward adult levels. As it falls, blood takes the easier path through a septal defect or ductus into the lungs. Qp (pulmonary flow) rises above Qs (systemic flow) , which causes:
- Pulmonary overcirculation and edema (tachypnea, retractions, crackles)
- Left atrial and ventricular volume overload (cardiomegaly, gallop)
Increased work of breathing and metabolic demand, leading to poor feeding, sweating with feeds , and failure to thrive
Timing matters on the exam: A large VSD is often quiet on day 1. Symptoms typically appear at about 4–8 weeks , when PVR has fallen. A newborn in shock on day 1 with a "VSD" should prompt a search for another lesion.
Lesion Key features Transport notes
Ventricular septal defect (VSD) Most common congenital heart defect; holosystolic murmur; large defects cause heart failure at 1–2 months Diuretics, avoid excess oxygen, support nutrition
Atrial septal defect (ASD) Usually asymptomatic in infancy; fixed split S2 Rarely a transport emergency on its own
Atrioventricular septal defect (AVSD) Common in Down syndrome (about 40–50% of people with trisomy 21 have congenital heart disease); early heart failure; pulmonary hypertension develops early Watch for pulmonary hypertensive crises
Patent ductus arteriosus (PDA) Continuous "machinery" murmur in older infants; in preterm infants, bounding pulses and wide pulse pressure See below
Truncus arteriosus Single great artery; cyanosis plus heart failure; associated with 22q11.2 deletion (check calcium, use irradiated blood) Balance Qp and Qs; hypocalcemia risk
Oxygen can make shunt lesions worse
Oxygen is a pulmonary vasodilator. In a large shunt, high FiO2 lowers PVR further and increases pulmonary overcirculation , worsening edema and stealing systemic flow. Titrate oxygen to the saturation target set with cardiology, often in the low-to-mid 90s for acyanotic shunts and 75–85% for single-ventricle physiology (Section 8.2).
The Patent Ductus Arteriosus in the Preterm Infant
In preterm infants, the ductus often stays open because the immature ductal tissue is sensitive to prostaglandins and responds less to oxygen. A hemodynamically significant PDA (hsPDA) shunts left to right as PVR falls, typically in the first week.
Signs:
- Bounding peripheral pulses and a wide pulse pressure (low diastolic pressure)
- Active precordium and a systolic or continuous murmur (sometimes silent when very large)
- Increasing ventilator or oxygen needs, pulmonary edema, and pulmonary hemorrhage
Systemic steal: Low diastolic pressure reduces flow to gut, kidneys, and brain, contributing to oliguria, feeding intolerance, and NEC risk
Management (receiving NICU decisions, supported in transport):
Adequate PEEP helps limit pulmonary overcirculation and edema.
Avoid fluid overload, and keep hematocrit in the target range.
Pharmacologic closure uses NSAIDs (indomethacin or ibuprofen) or acetaminophen . Contraindications for NSAIDs include active bleeding, significant thrombocytopenia, renal failure, and NEC.
Surgical ligation or catheter closure for refractory cases.
Remember the opposite situation: In ductal-dependent lesions (Sections 8.1–8.2), the ductus must be kept open with PGE1. Never give NSAIDs or acetaminophen for "PDA closure" until a ductal-dependent lesion has been excluded by echocardiography.
Obstructed Total Anomalous Pulmonary Venous Return (TAPVR)
In TAPVR, all pulmonary veins drain into the systemic venous circulation instead of the left atrium. When that pathway is obstructed (classically infracardiac drainage below the diaphragm), pulmonary venous blood backs up:
Severe cyanosis with pulmonary edema (diffuse ground-glass or reticular opacities) and often a small heart on radiograph
Respiratory failure and shock in the first hours or days of life
Easily mistaken for RDS, pneumonia, or PPHN . An echocardiogram is essential when "lung disease" responds poorly or when saturations are similar pre- and post-ductally.
Management: Obstructed TAPVR is a surgical emergency . PGE1 does not relieve the pulmonary venous obstruction, and increasing pulmonary blood flow can worsen edema. Transport focuses on ventilation with PEEP, inotropic support, correcting acidosis, and getting the infant to a cardiac surgical center quickly. Some teams arrange ECMO as a bridge.
Neonatal and Infant Heart Failure
Heart failure in infants rarely looks like adult heart failure. Signs include:
- Tachypnea and tachycardia at rest
- Poor feeding, sweating with feeds , and poor weight gain
Hepatomegaly (the infant's equivalent of peripheral edema; a liver edge more than 2–3 cm below the costal margin)
Gallop rhythm, cool extremities, and cardiomegaly on radiograph
Causes by timing:
First days: Ductal-dependent systemic lesions (as the ductus closes), critical aortic stenosis, cardiomyopathy (including hypertrophic cardiomyopathy in infants of diabetic mothers), large arteriovenous malformations (vein of Galen), myocarditis, and prolonged SVT (Section 8.3)
Weeks 4–8: Large left-to-right shunts
Transport management:
Avoid large fluid boluses. Give 5–10 mL/kg aliquots only if hypovolemia is likely, and reassess liver size and lungs after each.
Give diuretics (for example, furosemide) for pulmonary edema when perfusion allows.
Provide inotropic support (milrinone, dobutamine, or low-dose epinephrine; Section 6.1) for low output.
Use positive pressure and PEEP. They reduce left ventricular afterload and pulmonary edema but can lower preload, so watch blood pressure after intubation.
Titrate oxygen to targets rather than maximizing it in shunt lesions.
Consider PGE1 if a ductal-dependent systemic lesion is possible. A newborn in cardiogenic shock in the first two weeks has one until proven otherwise (Section 8.2).